Back to News
Market Impact: 0.38
TransMedics Group Q3 Earnings Call Highlights
Source: marketbeat.com
Corporate EarningsCorporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
TransMedics raised its full-year revenue outlook after reporting record third-quarter revenue and transplant case volume. Growth in its liver and heart businesses offset a decline in U.S. deceased donor volume; the article provides no revenue figures or magnitude for the volume changes.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
TMDX0.80
More News
- Election Fallout and Earnings Shake Up Wall Street
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- AI stocks hammered by midterm shock as data center buildout becomes a 'war of attrition'
- Fox completes its $22B acquisition of Roku